From: Comparison of health-related quality of life measures in chronic obstructive pulmonary disease
 | FEV 1 | 6MWT | Borg Dyspnea | SF-36 PCS | SF-36 MCS | EQ-5D index (UK) | EQ-5D index (US) | EQ-5D VAS | SGRQ Total | SGRQ Symptom | SGRQ Activity |
---|---|---|---|---|---|---|---|---|---|---|---|
FEV1 | 1 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
6MWT | 0.28†| 1 |  |  |  |  |  |  |  |  |  |
Borg Dyspnea | -0.41§ | -0.21†| 1 |  |  |  |  |  |  |  |  |
SF-36 PCS | 0.19†| 0.40§ | -0.58§ | 1 |  |  |  |  |  |  |  |
SF-36 MCS | 0.14 | 0.16 | -0.34§ | 0.15 | 1 |  |  |  |  |  |  |
EQ-5D Index(UK) | 0.01 | 0.21†| -0.48§ | 0.51§ | 0.54§ | 1 |  |  |  |  |  |
EQ-5D Index (US) | 0.03 | 0.21†| -0.48§ | 0.51§ | 0.56§ | 0.99§ | 1 |  |  |  |  |
EQ-5D VAS | 0.16 | 0.31§ | -0.48§ | 0.69§ | 0.49§ | 0.52§ | 0.53§ | 1 |  |  |  |
SGRQ Total | -0.43§ | -0.30§ | 0.76§ | -0.67§ | -0.50§ | -0.55§ | -0.57§ | -0.60§ | 1 |  |  |
SGRQ Symptom | -0.24†| -0.03 | 0.51§ | -0.42§ | -0.35§ | -0.36§ | -0.38§ | -0.36§ | 0.73§ | 1 |  |
SGRQ Activity | -0.45§ | -0.46§ | 0.70§ | -0.67§ | -0.40§ | -0.47§ | -0.48§ | -0.53§ | 0.88§ | 0.48§ | 1 |
SGRQ Impact | -0.36§ | -0.21†| 0.72§ | -0.59§ | -0.50§ | -0.56§ | -0.58§ | -0.60§ | 0.94§ | 0.63§ | 0.72§ |